Literature DB >> 7176328

Aggravation of experimental glomerulonephritis by superimposed clip hypertension.

J Neugarten, H D Feiner, R G Schacht, G R Gallo, D S Baldwin.   

Abstract

To evaluate the possible enhancing effect of hypertension on the clinical and morphologic features of glomerulonephritis, two-kidney clip hypertension (CH) was superimposed on a mild form of nephrotoxic serum nephritis (NSN) in female Sprague-Dawley rats. The following parameters were assessed regularly over a 6-month period: blood pressure (BP), heart weight, proteinuria (UpV), and renal morphology. Blood pressure and heart weights were increased equally in clip hypertension and in nephrotoxic serum nephritis combined with clip hypertension. While only moderate proteinuria occurred in nephrotoxic serum nephritis (49 +/- 28 mg/24 hr) or clip hypertension (40 +/- 22 mg/24 hr) alone, the superimposition of clip hypertension on nephrotoxic serum nephritis resulted in heavy proteinuria (161 +/- 36 mg/24 hr) (P less than 0.001) after 5 months of hypertension. Glomerular histology in nephrotoxic serum nephritis showed infrequent focal and segmental proliferation and minimal sclerosis; vessels were normal. Clip hypertension was characterized by infrequent and mild vascular sclerosis and glomerular proliferation and sclerosis. Severe glomerular endo- and extracapillary proliferation and widespread glomerular and vascular sclerosis occurred in the majority of rats when nephrotoxic serum nephritis was combined with clip hypertension. The data demonstrate that clip hypertension enhances glomerular proliferation and sclerosis and results in the development of vascular sclerosis in experimental nephritis.

Entities:  

Mesh:

Year:  1982        PMID: 7176328     DOI: 10.1038/ki.1982.163

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

1.  Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.

Authors:  P Heeringa; H van Goor; Y Itoh-Lindstrom; N Maeda; R J Falk; K J Assmann; C G Kallenberg; J C Jennette
Journal:  Am J Pathol       Date:  2000-03       Impact factor: 4.307

2.  David S. Baldwin, MD: a legacy in nephrology.

Authors:  Paul L Kimmel; Joel Neugarten; Jerome Lowenstein
Journal:  J Am Soc Nephrol       Date:  2014-08-22       Impact factor: 10.121

3.  Transfer of renovascular hypertension and coronary heart disease by lymphoid cells from SLE-prone mice.

Authors:  L Hang; P M Stephen-Larson; J P Henry; F J Dixon
Journal:  Am J Pathol       Date:  1984-04       Impact factor: 4.307

4.  [Loss of renal functional reserve following kidney transplantation and in patients with advanced disorders of liver function].

Authors:  T Eisenhauer; J Talartschik; H Hartmann; E Quentin; F Scheler
Journal:  Klin Wochenschr       Date:  1988-09-15

5.  The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage.

Authors:  I Shirato; H Hosser; K Kimura; T Sakai; Y Tomino; W Kriz
Journal:  Virchows Arch       Date:  1996-11       Impact factor: 4.064

6.  Studies of progressive glomerular sclerosis in the rat.

Authors:  S Adler; L J Striker; G E Striker; D T Perkinson; J Hibbert; W G Couser
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

7.  [Drug treatment of chronic glomerulonephritis: contra].

Authors:  K Andrassy; R Waldherr; E Ritz
Journal:  Klin Wochenschr       Date:  1985-09-16

8.  No aggravation of the course of experimental glomerulonephritis in spontaneously hypertensive rats.

Authors:  H D Stein; R B Sterzel; J D Hunt; R Pabst; M Kashgarian
Journal:  Am J Pathol       Date:  1986-03       Impact factor: 4.307

9.  Glomerular injury in uninephrectomized spontaneously hypertensive rats. A consequence of glomerular capillary hypertension.

Authors:  L D Dworkin; H D Feiner
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

10.  Selective inhibition of platelet thromboxane generation with low-dose aspirin does not protect rats with reduced renal mass from the development of progressive disease.

Authors:  C Zoja; A Benigni; M Livio; A Bergamelli; S Orisio; M Abbate; T Bertani; G Remuzzi
Journal:  Am J Pathol       Date:  1989-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.